AACR Annual Meeting 2016 Preview: Dr. José Baselga

preview_player
Показать описание
Рекомендации по теме
Комментарии
Автор

At a conference this year and before analysts in 2017, he put a positive spin on the results of two Roche-sponsored clinical trials that many others considered disappointments, without disclosing his relationship to the company. Since 2014, he has received more than $3 million from Roche in consulting fees and for his stake in a company it acquired...The New York Times article Sept. 8, 2018...(more) One of the world’s top breast cancer doctors (Dr. Jose Baselga) failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.

jcloud